{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:48:14Z","timestamp":1788281294815,"version":"build-2803163510"},"reference-count":11,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2001,10]]},"DOI":"10.1053\/ajkd.2001.27442","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T23:33:20Z","timestamp":1205796800000},"page":"S191-S194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"S","title":["A clinical trial in type 2 diabetic nephropathy"],"prefix":"10.1053","volume":"38","author":[{"given":"Edmund J","family":"Lewis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence G","family":"Hunsicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger A","family":"Rodby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/ajkd.2001.27442_BIB1","series-title":"USRDS 1998 Annual Data Report","author":"Renal Data System","year":"1998"},{"key":"10.1053\/ajkd.2001.27442_BIB2","first-page":"114","article-title":"Therapeutic interventions for nephropathy in type I diabetes mellitus","volume":"17","author":"Breyer","year":"1997","journal-title":"Semin Nephrol"},{"key":"10.1053\/ajkd.2001.27442_BIB3","first-page":"132","article-title":"Type II diabetic nephropathy: Its clinical course and therapeutic implications","volume":"17","author":"Rodby","year":"1997","journal-title":"Semin Nephrol"},{"key":"10.1053\/ajkd.2001.27442_BIB4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.7326\/0003-4819-118-2-199301150-00009","article-title":"Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis","volume":"118","author":"Kasiske","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1053\/ajkd.2001.27442_BIB5","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1053\/ajkd.2001.27442_BIB6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.1994.03510280037029","article-title":"Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria","volume":"271","author":"Viberti","year":"1994","journal-title":"JAMA"},{"key":"10.1053\/ajkd.2001.27442_BIB7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.303.6794.81","article-title":"Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria","volume":"303","author":"Mathiesen","year":"1991","journal-title":"BMJ"},{"key":"10.1053\/ajkd.2001.27442_BIB8","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/0003-4819-118-8-199304150-00001","article-title":"Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients","volume":"118","author":"Ravid","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1053\/ajkd.2001.27442_BIB9","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/ndt\/12.6.1095","article-title":"Antihypertensive treatment in nephropathy of type II diabetes: Role o the pharmacologic blockade of the renin-angiotensin system","volume":"12","author":"Rodby","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2001.27442_BIB10","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and the risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38","volume":"317","author":"UKPDS Study Group","year":"1998","journal-title":"BMJ"},{"key":"10.1053\/ajkd.2001.27442_BIB11","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2337\/diacare.19.10.1051","article-title":"An economic analysis of captopril in the treatment of diabetic nephropathy","volume":"19","author":"Rodby","year":"1996","journal-title":"Diabetes Care"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638601283279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638601283279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:22:20Z","timestamp":1759454540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638601283279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,10]]}},"alternative-id":["S0272638601283279"],"URL":"https:\/\/doi.org\/10.1053\/ajkd.2001.27442","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2001,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A clinical trial in type 2 diabetic nephropathy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/ajkd.2001.27442","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}